Last updated on January 2020

Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis

Brief description of study

The primary purpose of this study is to evaluate the safety and efficacy of ravulizumab for the treatment of participants with generalized myasthenia gravis (gMG).

Clinical Study Identifier: NCT03920293

Find a site near you

Start Over